Skip to main content

Table 1 Demographics for the 114 lung transplant recipients in the study

From: Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients

Characteristics N = 114
LTx, years 2001-2006
Recipient Age years, mean (range) 49 (10-68)
Female (%) 63
Donor Age years, mean (range) 42 (5-70)
Female (%) 55
CMV serostatus, n (%) D+/R+: 66 (58)
  D-/R+: 22 (19)
  D+/R-: 17 (15)
  D-/R -: 9 (8)
Tx type n (%)  
-Single 80 (70)
-Double 31 (27)
-Heart and lung 3 (3)
Pre-transplant diagnosis (%)  
-COPD 38
-IPF 20
-A1AT 18
-CF 6
-PAH + PH 6
-GVHD 3.5
-Scleroderma 3.5
-Eisenmenger syndrome 2
-Others 3
  1. R = recipient, D = donor, COPD = chronic obstructive pulmonary disease, CF = Cystic fibrosis, A1AT = alpha-1 antitrypsin deficiency with emphysema, IPF = idiopathic pulmonary fibrosis, PAH = pulmonary arterial hypertension, PH = pulmonary hypertension, GVHD = graft-versus-host disease.